Dr. Daniel K. Hellerstein, MD

Dr. Hellerstein practices at Daniel K Hellerstein MD in Cape Coral, Florida.

Dr. Hellerstein's NPI, 1790817278, was assigned on March 11, 2007. Dr. Hellerstein graduated from Cleveland Medical College, Homeopathic in 1983. Dr. Hellerstein holds Florida license ME 58634.

Dr. Hellerstein's primary practice is Daniel K Hellerstein MD, at 1419 SE 8th Ter, Cape Coral, FL 33990 in Lee County. The practice phone is (561) 650-0815.

Dr. Hellerstein's primary practice is Daniel K Hellerstein MD in Cape Coral, Florida. Dr. Hellerstein is also affiliated with HCA Florida JFK Hospital. The medical group on file is GenesisCare. Dmand AI also links Dr. Hellerstein to 2 more hospitals, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hellerstein practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Hellerstein's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Hellerstein is board certified in urology by the American Board of Urology. Dmand AI has Dr. Hellerstein's licenses on file in 5 states: Florida, Ohio, Georgia, Texas and Minnesota.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Hellerstein treats.

CMS data shows 1,167 Medicare services from Dr. Hellerstein across 11 procedure codes in 2024, for 413 Medicare patients. Medicare paid $78,502 for them.

CMS counts 413 Medicare patients who saw Dr. Hellerstein in 2024. The largest group is 75 to 84, with 182 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hellerstein's median patient age at 73, with 18% women.

In 2024, Dr. Hellerstein wrote 1,598 Medicare Part D claims for 396 patients. 95% of them were for generic drugs. CMS names the drug for 1,487 of them, across 23 drugs with 11 or more claims each, at $48,978 in total drug cost. In 2023, CMS named 1,200 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Hellerstein for performance year 2024, reported individually. Dr. Hellerstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Hellerstein in 2018. The most frequent topics are Ultrasonography, Prostatic Hyperplasia and Infertility, Male. Dr. Hellerstein has published most often in Urology. Dr. Hellerstein's most frequent co-authors are Larry I. Lipshultz, MD and Stuart Sacks, MD.

CMS Open Payments shows 14 general payments to Dr. Hellerstein from 6 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 52% of the total. PROCEPT BioRobotics Corporation paid the most, $1,724.

Dr. Hellerstein graduated from Cleveland Medical College, Homeopathic in 1983.

Dr. Hellerstein is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.